The global Biosimilar and Biologics Market was valued at USD 512.7 billion in 2024 and is projected to grow at a CAGR of 8.4% from 2025 to 2032. Market expansion is supported by the increasing prevalence of chronic diseases, patent expirations of major biologic drugs, rising demand for cost-effective therapeutic alternatives, and continuous advances in biopharmaceutical manufacturing and...

The Biosimilar And Biologics Market growth continues to accelerate as healthcare systems worldwide increasingly balance innovation-driven biologic therapies with cost-containment imperatives through biosimilar adoption. With biologics representing the fastest-growing segment of pharmaceutical expenditure and treating conditions from cancer and autoimmune diseases to diabetes and rare disorders,...